bluebird bio Inc (NASDAQ: BLUE) stock closed at $8.78 on 12/26/24 after a major increase of 12.7%. However, below average trading volume at 78% of normal accompanied the advance. The stock has declined -2.1% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
bluebird bio has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. bluebird bio has a poor Power Rating of 18 and a very low Appreciation Score of 2, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment